XXI Wealth’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
XXI Wealth's BIIB Position: Q3 2026 in Review
XXI Wealth increased its Biogen (BIIB) stake by 5.7% in Q3 2026, buying an estimated $43.9K and bringing the position to 3,810 shares worth $861K. The position accounts for 0.35% of the portfolio, ranked #68.
XXI Wealth first reported a position in BIIB in Q4 2025 and has held it in 4 quarters since. 899 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- XXI Wealth held 3,810 shares of Biogen worth $861K as of Q3 2026.
- XXI Wealth bought 207 Biogen shares in Q3 2026, an estimated $43.9K.
- Biogen made up 0.35% of XXI Wealth's portfolio in Q3 2026, its #68 holding.
- XXI Wealth first reported a position in Biogen in Q4 2025 and has held it in 4 quarters since.
- 899 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on XXI Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.